Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Automated Liquid Handling Systems
... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media
... Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Contrast Media, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$7.5 Billion ... Read More
-
Endocrine Testing
... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More
-
Fertility Services
... CAGR of 15.0% over the analysis period 2024-2030. Fresh Non-Donor Fertility Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of ... Read More
-
CBCT / Cone Beam Imaging
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Standing Patient Position, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$968.6 ... Read More
-
Cell Lysis / Cell Fractionation
... Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cell Lysis / Cell Fractionation Consumables, one of the segments analyzed in the report, is expected to record a 6.7% CAGR ... Read More
-
Cell Signaling
... CAGR of 5.4% over the analysis period 2024-2030. Cell Signaling Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram Test, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end ... Read More
-
Cell Proliferation Kits
... at a CAGR of 5.5% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$394.2 Million by ... Read More
-
Heavy Metal Testing
... at a CAGR of 4.7% over the analysis period 2024-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Influenza Diagnostics
... CAGR of 5.2% over the analysis period 2024-2030. RIDT Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Urinalysis
... 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Veterinary Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. Veterinary Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
X-Ray Crystallography
... CAGR of 11.4% over the analysis period 2024-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$944.5 Million by the end of the analysis ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth ... Read More
-
D-dimer Testing
... CAGR of 4.0% over the analysis period 2024-2030. D-dimer Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end ... Read More
-
Drugs of Abuse Testing
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Analyzers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.9 Billion by the end ... Read More
-
Hemostasis Diagnostics
... CAGR of 4.8% over the analysis period 2024-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Breath Analyzers
... CAGR of 15.4% over the analysis period 2024-2030. Fuel Cells Technology, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Dental Diagnostic Imaging Equipment
... 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Intraoral Imaging Systems, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More
-
Systemic Radiotherapy
... CAGR of 4.0% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of the analysis ... Read More
Research Assistance
